Instead of selling, average down, or just ride it out and wait for the upturn.
All pharma and biotech stocks getting hit since the Hillary speech.
CELG could also be another company's bait for merger.
You mentioned Citron covered their VRX short position - how much was his return, over 50%?
Just wondering at what price they covered at and price they shorted.
They have another winner at MNK, due to high cost of drugs.
SDS now at 19.33; should it go to 19.53, that's just a 10 point rise for S&P 500 at 2039.
Not much of a risk/reward.
Looks to be a sideways to slightly higher market when S&P 500 peaked at 2051.
I'll wait to buy SDS should it go under 19.00
IMO S&P 500 will have a small spike 2070-2100 max, then fizzle reversal down.
First quarter window dressing ends this Thursday....with S&P 500 monthly return of 4% - 6%, compared to Jan & Feb losses.
Fear of a potential interest rate by Feds in April weigh in market fears.
Microsoft to make its 2nd attempt to buy Yahoo, Verizon next in line.
It will happen, almost certain Yahoo to find new leader to run this company which lost its golden touch.
Good try MM but not good enough.
Stoxline only gives a one-day recommendation and changes all the time.
Better option is to buy some AGN at these prices and average down, wait and AGN should be at 350 by end of 2016.
The big boys don't want to tie up their money for that long a period.
And, 2 years from now after the merger, plans in place for bigger and better events to happen.
I wonder what makes this stock rarely go down even on corrections.
Or, will it one day return to 70s or get to over 95 first.
What makes TTC so special to buck the trend...any experts out there know?
Tell us your entry buy point for UVXY so we can follow your progress winning trade, and your target price to sell.
This was a great buy beginning of the year 2016 from 19 to 23, but gave it all back.
SDS feels like its going lower to 17.50-19.00 range, then zoom, reverse direction to 23 again.
All a repeat of 2015 again IMO.
Today's news on Reuters.co - go and read it.
Comparison to Enron and Worldcom with multiple organ failure puts it in ICU.
Creative accounting issue will kill all companies.
Just relaying the message to all.
Did you own VRX in the past?
Or are you short VRX now waiting for a lower price under 20
HOT took the first offer too low...MAR low-ball first offer thinking no other bids coming.
Maybe market feels a higher bidding war coming...
Don't get greedy to hold until the end.
"I wonder if the politicians will have any effect on the lobbyists and drug companies ..."
The short-term effect as you can see is depressed health care and biopharma stock prices across the board due to the Hillary speech when she gets elected.
Every election it is the same rhetoric but doesn't happen...remember year's past when hubby Bill ran for pres?
Ride this one out, GILD higher stock price by end of year with a company to purchase anticipation. You get a dividend while waiting.
Looks like many like VRX for a day trade bounce either up or down for a quick profit....not a long term hold as the music can stop at any given moment.
100% guarantee VRX won't go over 100 soon unless there is a reverse stock split.
This is a toxic stock whose best days are behind it...miracles to save longs buying at over 100 ain't going to happen.
not my words but according to Barron's recent 3/21/16 article.
Barron's figure there will be goodwill goodwill write-offs.
Balance sheet has $40B and comparison to Enron.
Creative accounting will kill all stocks...just give it time VRX to teens, the single digits.
History will repeat.
Is Barron's full of beans or could be the truth.